Veracyte (VCYT) Payables (2012 - 2026)

Veracyte has reported Payables for 15 years, with the latest figure at $8.0 million in Q2 2026.

• Payables for Q2 2026 came in at $8.0 million, down 29.9% year-over-year; the trailing twelve-month figure through Jun 2026 was $8.0 million (down 29.9% YoY), and the FY2025 annual result was $4.6 million, down 46.8% from the prior year.
• Payables grew to $8.0 million in Q2 2026, from $6.9 million in the prior quarter.
• Over five years, Payables peaked at $15.7 million in Q1 2025 and troughed at $4.6 million in Q4 2025.
• A 5-year average of $10.7 million and a median of $11.4 million in 2022 frame the typical range for Payables.
• The widest annual swing landed in 2022, when Payables soared 57.95%; it then tumbled 56.03% in 2026.
• A 5-year view of Payables shows it stood at $11.9 million in 2022, then grew by 8.66% to $12.9 million in 2023, then slumped by 33.29% to $8.6 million in 2024, then sank by 46.8% to $4.6 million in 2025, then jumped by 74.7% to $8.0 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $8.0 million in Q2 2026, $6.9 million in Q1 2026, and $4.6 million in Q4 2025.